TWi Pharmaceuticals Inc (4180):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:TWi Pharmaceuticals Inc (4180) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8218
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
TWi Pharmaceuticals Inc (TWi), formerly Anchen Pharmaceuticals (Taiwan) Inc is a technology based pharmaceutical company that manufactures high barrier generics drugs. The company provides products such as donepezil hydrochloride tablets, hydroquinone cream, hydroquinone time release cream, megestrol acetate oral suspension and nifedipine extended-release tablets, among others. Its drugs consists of oral controlled release dosage form, non-oral parental and transdermal products, novel drug delivery systems, polymeric oral delivery systems, and others. TWi develops oral high barrier generic prescription products for muscle relaxants, hypertension, vasospatic agina, anorexia, cachexia, alzheimar’s diseases, and others. The company operates in Taiwan. TWi is headquartered in Taipei, Taiwan.

TWi Pharmaceuticals Inc (4180) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
TWi Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
TWi Pharma Enters into Agreement with Intech Biopharm 11
Licensing Agreements 12
Castle Creek Pharma Enters into Licensing Agreement with TWi Biotechnology 12
Equity Offering 13
TWi Biotechnology to Raise USD17.5 Million in IPO 13
TWi Pharma Raises USD87 Million in Public Offering of Global Depository Receipts 14
TWi Pharma Completes IPO 15
TWi Pharma Announces Private Placement Of Shares For US$11 Million 16
Acquisition 17
TWi Pharmaceutical Cayman to Sell its Stake in Hainan-Based Pharmaceuticals Company for USD28.6 Million 17
TWi Pharma to Acquire 50% Stake in Hainan Visum Pharma 18
TWi Pharma Acquires U-Liang Pharma 19
TWi Pharmaceuticals Inc – Key Competitors 20
TWi Pharmaceuticals Inc – Key Employees 21
TWi Pharmaceuticals Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TWi Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
TWi Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
TWi Pharma Enters into Agreement with Intech Biopharm 11
Castle Creek Pharma Enters into Licensing Agreement with TWi Biotechnology 12
TWi Biotechnology to Raise USD17.5 Million in IPO 13
TWi Pharma Raises USD87 Million in Public Offering of Global Depository Receipts 14
TWi Pharma Completes IPO 15
TWi Pharma Announces Private Placement Of Shares For US$11 Million 16
TWi Pharmaceutical Cayman to Sell its Stake in Hainan-Based Pharmaceuticals Company for USD28.6 Million 17
TWi Pharma to Acquire 50% Stake in Hainan Visum Pharma 18
TWi Pharma Acquires U-Liang Pharma 19
TWi Pharmaceuticals Inc, Key Competitors 20
TWi Pharmaceuticals Inc, Key Employees 21
TWi Pharmaceuticals Inc, Other Locations 22
TWi Pharmaceuticals Inc, Subsidiaries 22

List of Figures
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TWi Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
TWi Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[TWi Pharmaceuticals Inc (4180):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Golden Ocean Group Limited:企業のM&A・事業提携・投資動向
    Golden Ocean Group Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Golden Ocean Group Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Akonni Biosystems Inc-医療機器分野:企業M&A・提携分析
    Summary Akonni Biosystems Inc (Akonni Biosystems) is a molecular diagnostics company that develops, manufactures, and distributes integrated molecular diagnostic systems. The company’s products include nucleic acid extraction kits, molecular diagnostic tests, thermal cyclers, microarray readers and …
  • Petrolympic Ltd (PCQ):石油・ガス:M&Aディール及び事業提携情報
    Summary Petrolympic Ltd (Petrolympic) is an oil and gas exploration and development company that acquires, explores and develops light crude oil and natural gas in North America. The company holds interests in conventional natural gas and light oil projects in Gaspe Peninsula of Quebec. It holds int …
  • IntraPace Inc:医療機器:M&Aディール及び事業提携情報
    Summary IntraPace Inc (IntraPace) is a medical device company that develops novel implantable systems. The company offers abiliti systems that contain sensors intended to track consumption events and physical activity to direct when therapy is delivered and to monitor a patient's progress toward wei …
  • Azul SA (AZUL):企業の財務・戦略的SWOT分析
    Azul SA (AZUL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Sanofi (SAN):企業の財務・戦略的SWOT分析
    Sanofi (SAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Asterand Bioscience Inc-製薬・医療分野:企業M&A・提携分析
    Summary Asterand Bioscience Inc (Asterand) is a biopharmaceutical company that offers tissue based products and contract research services. The company offers human tissue and human tissue-based research solutions to drug discovery scientists. Its products include biospecimens, human tissue and biof …
  • Manz AG (M5Z)-エネルギー分野:企業M&A・提携分析
    Summary Manz AG (Manz) is a manufacturer of high-technology equipment. It produces displays, printed circuit boards and other components for electronic devices. The company provides production equipment for lithium-ion battery cells, super capacitors, battery systems, and capacitors. Manz offers ind …
  • Malayan Flour Mills Berhad:戦略・SWOT・企業財務分析
    Malayan Flour Mills Berhad - Strategy, SWOT and Corporate Finance Report Summary Malayan Flour Mills Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Power Corporation of Canada:企業の戦略・SWOT・財務分析
    Power Corporation of Canada - Strategy, SWOT and Corporate Finance Report Summary Power Corporation of Canada - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • BFS Group Limited:企業の戦略・SWOT・財務情報
    BFS Group Limited - Strategy, SWOT and Corporate Finance Report Summary BFS Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • KBC Group NV:企業のM&A・事業提携・投資動向
    KBC Group NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's KBC Group NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Haier Group:企業の戦略・SWOT・財務情報
    Haier Group - Strategy, SWOT and Corporate Finance Report Summary Haier Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Rexel S.A.:企業の戦略・SWOT・財務分析
    Rexel S.A. - Strategy, SWOT and Corporate Finance Report Summary Rexel S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Cancer Genetics Inc (CGIX):企業の財務・戦略的SWOT分析
    Summary Cancer Genetics Inc (CGI) is a pharmaceutical company that offers diagnostic products and services enabling precision medicine in the field of oncology. It offers products such as CGH microarrays, next-generation sequencing and DNA-FISH Probes. The company's oncology tests and laboratory ser …
  • Medibank Private Limited (MPL):企業の財務・戦略的SWOT分析
    Medibank Private Limited (MPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • SPI Energy Co Ltd:電力:M&Aディール及び事業提携情報
    Summary Spi Energy Co Ltd (Spi Energy), formerly Solar Power Inc, is a photovoltaic (PV) solutions provider. The company offers development, financing, installation, operation and sale of utility-scale and residential solar power projects. It also operates online energy e-commerce and investment pla …
  • Alacer Gold Corp:企業の戦略・SWOT・財務情報
    Alacer Gold Corp - Strategy, SWOT and Corporate Finance Report Summary Alacer Gold Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • ICICI Bank Ltd:企業のM&A・事業提携・投資動向
    ICICI Bank Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ICICI Bank Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • XState Resources Ltd (XST):企業の財務・戦略的SWOT分析
    Summary XState Resources Ltd (XState Resources) is an oil and gas exploration and development company. The company’s business activities include acquisition, exploration, production and development of oil and gas assets. It holds interest in producing gas wells and associated land leases and product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆